Abstract: A low-cost cryptographic accelerator is disclosed that accelerates inner loops of a cryptographic process. The cryptographic accelerator performs operations on cryptographic data provided by a central processing unit (CPU) running a software cryptographic process to create a combined hardware and software cryptographic process, resulting in a lower cost secure communication solution than software-only or hardware-only cryptographic processes.

Abstract: The present invention relates to methods and products for isolating nucleic acids from samples containing biological material. In particular, the present invention relates to silica-coated magnetic particles, processes for their preparation and their use in methods of isolating nucleic acids samples containing biological material.

Abstract: A data processing system is disclosed that includes one or more processors that can perform producer processes to produce work and consumer processes that can consume work produced by a producer process. The system includes a pool of plural communication resources that may be used for communications between a producer process and a consumer process. The system tracks the usage of communication resources of the pool of communication resources, and allocates a communication resource from the pool of communication resources based on the tracking.

Abstract: A low-cost cryptographic accelerator is disclosed that accelerates inner loops of a cryptographic process. The cryptographic accelerator performs operations on cryptographic data provided by a central processing unit (CPU) running a software cryptographic process to create a combined hardware and software cryptographic process, resulting in a lower cost secure communication solution than software-only or hardware-only cryptographic processes.

Abstract: When a processing resource of a data processing system is to perform processing tasks for applications executing on a host processor, the host processor prepares a plurality of command streams to cause the processing resource to perform the processing tasks. When a processing task to be added to a command stream has a dependency on a processing task or tasks that will be included in another command stream, a wait command is added to the command stream that is to include the processing task that has a dependency on a processing task or tasks that will be included in the another command stream, to cause the processing resource to delay executing subsequent commands in the command stream after the wait command, until the processing resource has reached a particular position in the another command stream.

Abstract: When executing a program on a data processor comprising an execution unit for executing instructions in a program to be executed by the data processor, the execution unit being associated with one or more hardware units operable to execute instructions, at least one instruction in a program is associated with an indication of whether the instruction should be issued directly for execution by a hardware unit or should be intercepted during its execution by the execution unit. The execution unit then, when decoding the instruction for execution by a hardware unit in the program, determines from the indication associated with the instruction whether the instruction should be issued directly for execution by a hardware unit or intercepted during its execution by the execution unit, and issues the instruction for execution by a hardware unit directly, or pauses execution of the instruction and performs another operation, accordingly.

Abstract: A low-cost cryptographic accelerator is disclosed that accelerates inner loops of a cryptographic process. The cryptographic accelerator performs operations on cryptographic data provided by a central processing unit (CPU) running a software cryptographic process to create a combined hardware and software cryptographic process, resulting in a lower cost secure communication solution than software-only or hardware-only cryptographic processes.

Abstract: When executing a program on a data processor comprising an execution unit for executing instructions in a program to be executed by the data processor, the execution unit being associated with one or more hardware units operable to execute instructions, at least one instruction in a program is associated with an indication of whether the instruction should be issued directly for execution by a hardware unit or should be intercepted during its execution by the execution unit. The execution unit then, when decoding the instruction for execution by a hardware unit in the program, determines from the indication associated with the instruction whether the instruction should be issued directly for execution by a hardware unit or intercepted during its execution by the execution unit, and issues the instruction for execution by a hardware unit directly, or pauses execution of the instruction and performs another operation, accordingly.

Abstract: When a processing resource of a data processing system is to perform processing tasks for applications executing on a host processor, the host processor prepares a plurality of command streams to cause the processing resource to perform the processing tasks. When a processing task to be added to a command stream has a dependency on a processing task or tasks that will be included in another command stream, a wait command is added to the command stream that is to include the processing task that has a dependency on a processing task or tasks that will be included in the another command stream, to cause the processing resource to delay executing subsequent commands in the command stream after the wait command, until the processing resource has reached a particular position in the another command stream.

Abstract: Disclosed is A method of treatment of a disorder or condition where it is desirable to inhibit the growth of cells, or a method of treatment which involves cytostatic therapy by administering an oligopeptidic compound to a subject in need thereof. The oligopeptidic compound is capable of interacting with proliferating cell nuclear antigen (PCNA) The compound comprises a PCNA interacting motif which is: which is: [K/R]-[F/Y/W]-[L/I/V/A/M]-[L/I/V/A/M]-[K/R] (SEQ ID NO. 28). The oligopeptidic compound has 9-70 subunits and at least one signal sequence. The signal sequence is a nuclear localization signal sequence and/or a cell penetrating signal sequence. In the compound a PCNA interacting motif is N-terminal to a signal sequence.

Abstract: In an embodiment, a circuit comprises: an analog driver operable to drive a sensor voltage on a capacitive sensor; a digital driver; a shield drive control coupled to the analog driver and the digital driver, the shield drive control operable to: during a one or more phases of a capacitive measurement of the capacitive sensor, disable the analog driver and enable the digital driver to drive a driven shield; and during one or more other phases of a capacitive measurement of the capacitive sensor, disable the digital driver and enable the analog driver to drive the driven shield with a driven shield voltage that replicates the sensor voltage.

Abstract: A low-cost cryptographic accelerator is disclosed that accelerates inner loops of a cryptographic process. The cryptographic accelerator performs operations on cryptographic data provided by a central processing unit (CPU) running a software cryptographic process to create a combined hardware and software cryptographic process, resulting in a lower cost secure communication solution than software-only or hardware-only cryptographic processes.

Abstract: In an embodiment, a circuit comprises: an analog driver operable to drive a sensor voltage on a capacitive sensor; a digital driver; a shield drive control coupled to the analog driver and the digital driver, the shield drive control operable to: during a one or more phases of a capacitive measurement of the capacitive sensor, disable the analog driver and enable the digital driver to drive a driven shield; and during one or more other phases of a capacitive measurement of the capacitive sensor, disable the digital driver and enable the analog driver to drive the driven shield with a driven shield voltage that replicates the sensor voltage.

Abstract: Disclosed is A method of treatment of a disorder or condition where it is desirable to inhibit the growth of cells, or a method of treatment which involves cytostatic therapy by administering an oligopeptidic compound to a subject in need thereof. The oligopeptidic compound is capable of interacting with proliferating cell nuclear antigen (PCNA) The compound comprises a PCNA interacting motif which is: which is: [K/R]-[F/Y/W]-[L/I/V/A/M]-[L/I/V/A/M]-[K/R] (SEQ ID NO. 28). The oligopeptidic compound has 9-70 subunits and at least one signal sequence. The signal sequence is a nuclear localization signal sequence and/or a cell penetrating signal sequence. In the compound a PCNA interacting motif is N-terminal to a signal sequence.

Abstract: Disclosed is an oligopeptidic compound capable of interacting with proliferating cell nuclear antigen (PCNA), wherein the compound comprises a PCNA interacting motif which is: (SEQ?ID?NO.?28) [K/R]-[F/Y/W]-[L/I/V/A/M]-[L/I/V/A/M]-[K/R]; wherein the oligopeptidic compound has 9-70 subunits and comprises at least one signal sequence, wherein the signal sequence is a nuclear localization signal sequence and/or a cell penetrating signal sequence and wherein in said compound a PCNA interacting motif is N-terminal to a signal sequence. Also disclosed are methods of treatment of a disorder or condition where it is desirable to inhibit the growth of cells, or a method of treatment which involves cytostatic therapy, or a method of treatment of inflammation said method comprising administering the oligopeptidic compound to a subject in need thereof.

Abstract: A battery management and protection system can include various features to improve safety-critical and other functions. Among the features that can be included in some implementations are automatic loading of safety or other parameters during start-up of the system; a centralized timekeeper and an event system that can trigger actions in the system independently of a central processing unit; use of the same modules for both automatically-controlled safety-related measurements and firmware-controlled measurements; enhanced diagnostic features, and a sleepwalking feature that allows certain modules in the system to continue to perform various functions even when the module or the system is in a low-power sleep mode.

Abstract: Disclosed is an oligopeptidic compound capable of interacting with proliferating cell nuclear antigen (PCNA), wherein the compound comprises a PCNA interacting motif which is: (SEQ?ID?NO.?28) [K/R]-[F/Y/W]-[L/I/V/A/M]-[L/I/V/A/M]-[K/R]; wherein the oligopeptidic compound has 9-70 subunits and comprises at least one signal sequence, wherein the signal sequence is a nuclear localization signal sequence and/or a cell penetrating signal sequence and wherein in said compound a PCNA interacting motif is N-terminal to a signal sequence. Also disclosed are methods of treatment of a disorder or condition where it is desirable to inhibit the growth of cells, or a method of treatment which involves cytostatic therapy, or a method of treatment of inflammation said method comprising administering the oligopeptidic compound to a subject in need thereof.

Abstract: A battery management and protection system can include various features to improve safety-critical and other functions. Among the features that can be included in some implementations are automatic loading of safety or other parameters during start-up of the system; a centralized timekeeper and an event system that can trigger actions in the system independently of a central processing unit; use of the same modules for both automatically-controlled safety-related measurements and firmware-controlled measurements; enhanced diagnostic features, and a sleepwalking feature that allows certain modules in the system to continue to perform various functions even when the module or the system is in a low-power sleep mode.

Abstract: The present invention provides an oligopeptidic compound comprising a PCNA interacting motif, or a nucleic acid molecule comprising a sequence encoding said oligopeptidic compound, for use in therapy, wherein the PCNA interacting motif is X1X2X3X3?X1?- (SEQ ID NO: 1), wherein X1 and X1?- are independently selected from the group of basic amino acids, X2 is a lipophilic amino acid and X3 and X3? are independently selected from the group of uncharged amino acids; and wherein the oligopeptidic compound is further characterized by at least one of the following: (i) the oligopeptidic compound comprises at least one signal sequence; (ii) the PCNA interacting motif is [K/R]-F-[L/I/V]-[L/I/V]-[K/R] (SEQ ID NO: 27). Particularly the therapy may be the treatment of a disorder or condition where it is desirable to inhibit the growth of cells, for example a hyperproliferative disorder, or a treatment which involves cytostatic therapy e.g., myeloablation.

Abstract: A method and system utilized with an analog to digital converter is disclosed. The method and system comprise providing a first conversion on an input signal. In the first conversion, an offset error is added to the input signal to provide a first result. The method and system further includes providing a second conversion on the input signal. In the second conversion, an offset error is subtracted from the input signal to provide a second result. The first and second results are then combined to substantially remove the offset error. A system and method in accordance with the present invention compensates for the accumulated offset error over many samples, thereby achieving much higher accuracy in the offset error compensation.